Wall Street stock indexes fell in mid-August 2026 as Brent crude oil prices climbed above $90 per barrel amid heightened geopolitical risks tied to the Iran war and broader Middle East violence [1, 2, 3, 4, 5, 6]. The US 30-year Treasury yield reached its highest level since 2007, trading around 5.3%, while the 10-year yield hovered near multi-year highs of approximately 4.7%-4.75% [1, 2, 3, 4, 5, 7, 6, 8, 9]. Traders expressed concern that rising long-term yields and soaring energy costs would pressure stocks and complicate inflation control [2, 3, 5, 7, 6].

The expiration of the US-Iran ceasefire agreement on August 17, with President Donald Trump stating he would not seek an extension, further dimmed prospects for peace and intensified market caution [2, 3, 4]. Renewed fighting in Lebanon and stalemates over the Strait of Hormuz increased geopolitical uncertainty, contributing to oil supply risk fears [2, 3, 5, 7, 6]. "The combination of higher energy costs and higher long-term borrowing costs is becoming increasingly uncomfortable," said Fawad Razaqzada of Forex.com [5]. Kim Forrest of Bokeh Capital Partners added, "The yields are troubling people because it portends a tighter environment and it's going to be more expensive to borrow money." [4]

Technology shares showed mixed volatility. Semiconductor companies, including Nvidia, experienced selling pressure ahead of key earnings, weighing on the chip sector and broader market sentiment [4, 5, 7, 10]. South Korean chip stocks like Samsung Electronics and SK Hynix led declines, dropping over 8% amid geopolitical tensions and bond yield worries [10, 6]. Meanwhile, large software firms such as Microsoft and Meta slipped sharply [11, 3, 4]. RBC's Lori Calvasina noted, "Fed policy uncertainty, potential rate hikes and valuation concerns may not be enough to derail the equity rally," pointing to underlying resilience [1].

On the corporate front, Anthropic PBC reported a surge in second-quarter revenue to more than $11.5 billion with positive adjusted operating income, drawing renewed investor interest in AI-related tech stocks [11, 3]. Reuters had recently forecast Anthropic's 2028 revenue at close to $190-$200 billion ahead of its IPO [11]. Moderna shares surged approximately 177% after announcing positive late-stage trial results for a personalized mRNA cancer therapy developed with Merck, with gains boosting biotech sentiment [8, 12].

Consumer sector stocks faced pressure. Walmart missed quarterly sales expectations, causing its stock to drop 8.6% and dragging down the consumer staples sector [9]. Investors were cautious ahead of major US retail earnings reports from Home Depot on August 18 and Walmart on August 20, seeking signs on consumer spending trends [11, 4, 8, 9]. Phil Blancato of Osaic Wealth said concerns over softer recent data have market participants "waiting for retail earnings for direction." [11]

The US dollar weakened to its lowest level since May amid these dynamics, with Asian currencies showing mixed performance [3, 6]. In response to market pressures, the US Treasury doubled liquidity support buyback operations for long-dated bonds, temporarily easing bond yield spikes [8, 12]. Carol Schleif of BMO Private Wealth said, "The risk-on trade is trying to hang on to the lifeline that Treasury Secretary Bessent sent." [12]

The Federal Reserve's July meeting minutes revealed concerns over persistent inflation and that "several" policymakers stood ready to raise interest rates if needed, sustaining speculation of further hikes [12]. JPMorgan's Kay Herr remarked, "The market really doesn’t really love the fact that we don’t have forward guidance," highlighting investor unease [7].

US stocks rebounded on August 19 after bond yields retreated and Moderna shares surged, but fell again on August 20 as yields rose and Walmart’s weak sales weighed on sentiment [8, 12, 9]. The market remains cautious with retail earnings and bond yield moves poised to affect stock direction in the near term.